Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.
Increase in opioid epidemic in the U.S. coupled with establishment of government policies to control the crisis is driving the market.
The report details the trend, potential and market size of Opioid Use Disorder market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Opioid Use Disordermarket, defines the market attractiveness level of Opioid Use Disorder market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Opioid Use Disorder industry, describes the types of Opioid Use Disorder market, the applications of major players and the market size, and deeply analyzes the current situation of the global Opioid Use Disorder market and the development prospects and opportunities of Opioid Use Disorder industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Opioid Use Disorder market in Chapter 13.
By Player:
Hikma Pharmaceuticals
Teva Pharmaceuticals
Titan Pharmaceuticals
Omeros
Pfizer, Inc
BioDelivery Sciences International Inc
Alkermes
Indivior
Camurus
MediciNova
Orexo
Mallinckrodt Pharmaceuticals
By Type:
Buprenorphine
Methadone
Naltrexone
By End-User:
Severe Pain Treatment
Moderate Pain Treatment
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Opioid Use Disorder Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Opioid Use Disorder Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Opioid Use Disorder Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Opioid Use Disorder Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Opioid Use Disorder Market Analysis and Outlook to 2022
-
7.1 Global Opioid Use Disorder Consumption (2017-2022)
-
7.2 United States Opioid Use Disorder Consumption (2017-2022)
-
7.3 Europe Opioid Use Disorder Consumption (2017-2022)
-
7.4 China Opioid Use Disorder Consumption (2017-2022)
-
7.5 Japan Opioid Use Disorder Consumption (2017-2022)
-
7.6 India Opioid Use Disorder Consumption (2017-2022)
-
7.7 South Korea Opioid Use Disorder Consumption (2017-2022)
8 Region and Country-wise Opioid Use Disorder Market Analysis and Outlook to 2028
-
8.1 Global Opioid Use Disorder Consumption Forecast (2022-2028)
-
8.2 United States Opioid Use Disorder Consumption Forecast (2022-2028)
-
8.3 Europe Opioid Use Disorder Consumption Forecast (2022-2028)
-
8.4 China Opioid Use Disorder Consumption Forecast (2022-2028)
-
8.5 Japan Opioid Use Disorder Consumption Forecast (2022-2028)
-
8.6 India Opioid Use Disorder Consumption Forecast (2022-2028)
-
8.7 South Korea Opioid Use Disorder Consumption Forecast (2022-2028)
9 Global Opioid Use Disorder Market Outlook by Types and Applications to 2022
-
9.1 Global Opioid Use Disorder Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Buprenorphine Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Methadone Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Naltrexone Consumption and Growth Rate (2017-2022)
-
9.2 Global Opioid Use Disorder Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Severe Pain Treatment Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Moderate Pain Treatment Consumption and Growth Rate (2017-2022)
10 Global Opioid Use Disorder Market Outlook by Types and Applications to 2028
-
10.1 Global Opioid Use Disorder Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Buprenorphine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Methadone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Naltrexone Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Opioid Use Disorder Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Severe Pain Treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Moderate Pain Treatment Consumption Forecast and Growth Rate (2022-2028)
11 Global Opioid Use Disorder Import and Export Analysis (Top 5 Countries)
-
11.1 Global Opioid Use Disorder Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Opioid Use Disorder Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Opioid Use Disorder Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Opioid Use Disorder Market Competitive Analysis
-
14.1 Hikma Pharmaceuticals
-
14.1.1 Hikma Pharmaceuticals Company Details
-
14.1.2 Hikma Pharmaceuticals Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Hikma Pharmaceuticals Opioid Use Disorder Product and Service
-
14.2 Teva Pharmaceuticals
-
14.2.1 Teva Pharmaceuticals Company Details
-
14.2.2 Teva Pharmaceuticals Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Teva Pharmaceuticals Opioid Use Disorder Product and Service
-
14.3 Titan Pharmaceuticals
-
14.3.1 Titan Pharmaceuticals Company Details
-
14.3.2 Titan Pharmaceuticals Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Titan Pharmaceuticals Opioid Use Disorder Product and Service
-
14.4 Omeros
-
14.4.1 Omeros Company Details
-
14.4.2 Omeros Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Omeros Opioid Use Disorder Product and Service
-
14.5 Pfizer, Inc
-
14.5.1 Pfizer, Inc Company Details
-
14.5.2 Pfizer, Inc Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer, Inc Opioid Use Disorder Product and Service
-
14.6 BioDelivery Sciences International Inc
-
14.6.1 BioDelivery Sciences International Inc Company Details
-
14.6.2 BioDelivery Sciences International Inc Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 BioDelivery Sciences International Inc Opioid Use Disorder Product and Service
-
14.7 Alkermes
-
14.7.1 Alkermes Company Details
-
14.7.2 Alkermes Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Alkermes Opioid Use Disorder Product and Service
-
14.8 Indivior
-
14.8.1 Indivior Company Details
-
14.8.2 Indivior Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Indivior Opioid Use Disorder Product and Service
-
14.9 Camurus
-
14.9.1 Camurus Company Details
-
14.9.2 Camurus Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Camurus Opioid Use Disorder Product and Service
-
14.10 MediciNova
-
14.10.1 MediciNova Company Details
-
14.10.2 MediciNova Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 MediciNova Opioid Use Disorder Product and Service
-
14.11 Orexo
-
14.11.1 Orexo Company Details
-
14.11.2 Orexo Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Orexo Opioid Use Disorder Product and Service
-
14.12 Mallinckrodt Pharmaceuticals
-
14.12.1 Mallinckrodt Pharmaceuticals Company Details
-
14.12.2 Mallinckrodt Pharmaceuticals Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Mallinckrodt Pharmaceuticals Opioid Use Disorder Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Opioid Use Disorder
-
Figure Opioid Use Disorder Picture
-
Table Global Opioid Use Disorder Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Opioid Use Disorder Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Opioid Use Disorder Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Opioid Use Disorder Consumption by Country (2017-2022)
-
Figure United States Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Table Europe Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure China Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Japan Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure India Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure South Korea Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Global Opioid Use Disorder Consumption Forecast by Country (2022-2028)
-
Figure United States Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Buprenorphine Consumption and Growth Rate (2017-2022)
-
Figure Global Methadone Consumption and Growth Rate (2017-2022)
-
Figure Global Naltrexone Consumption and Growth Rate (2017-2022)
-
Figure Global Severe Pain Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Moderate Pain Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Buprenorphine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Methadone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Naltrexone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Severe Pain Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Moderate Pain Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Opioid Use Disorder Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Opioid Use Disorder Export by Region (Top 5 Countries) (2017-2028)
-
Table Hikma Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Hikma Pharmaceuticals Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hikma Pharmaceuticals Opioid Use Disorder Product and Service
-
Table Teva Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceuticals Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceuticals Opioid Use Disorder Product and Service
-
Table Titan Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Titan Pharmaceuticals Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Titan Pharmaceuticals Opioid Use Disorder Product and Service
-
Table Omeros (Foundation Year, Company Profile and etc.)
-
Table Omeros Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Omeros Opioid Use Disorder Product and Service
-
Table Pfizer, Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer, Inc Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer, Inc Opioid Use Disorder Product and Service
-
Table BioDelivery Sciences International Inc (Foundation Year, Company Profile and etc.)
-
Table BioDelivery Sciences International Inc Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioDelivery Sciences International Inc Opioid Use Disorder Product and Service
-
Table Alkermes (Foundation Year, Company Profile and etc.)
-
Table Alkermes Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alkermes Opioid Use Disorder Product and Service
-
Table Indivior (Foundation Year, Company Profile and etc.)
-
Table Indivior Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Indivior Opioid Use Disorder Product and Service
-
Table Camurus (Foundation Year, Company Profile and etc.)
-
Table Camurus Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Camurus Opioid Use Disorder Product and Service
-
Table MediciNova (Foundation Year, Company Profile and etc.)
-
Table MediciNova Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table MediciNova Opioid Use Disorder Product and Service
-
Table Orexo (Foundation Year, Company Profile and etc.)
-
Table Orexo Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Orexo Opioid Use Disorder Product and Service
-
Table Mallinckrodt Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Mallinckrodt Pharmaceuticals Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mallinckrodt Pharmaceuticals Opioid Use Disorder Product and Service
-
